| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052568822 |
| P356 | DOI | 10.1007/S12265-013-9534-4 |
| P8608 | Fatcat ID | release_j5eot6ufi5hwrphas33phnrrji |
| P698 | PubMed publication ID | 24469554 |
| P50 | author | Betti Giusti | Q42167367 |
| Rossella Marcucci | Q42167382 | ||
| Cinzia Fatini | Q114309906 | ||
| Rosanna Abbate | Q114309910 | ||
| Gabriele Cioni | Q114456459 | ||
| P2093 | author name string | Lorenza Rossi | |
| Maddalena Pazzi | |||
| P2860 | cites work | Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 |
| Platelet hyperreactivity in women from families with premature atherosclerosis | Q28166263 | ||
| Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males | Q28166354 | ||
| Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? | Q28168661 | ||
| Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project | Q28176142 | ||
| Low-dose aspirin increases aspirin resistance in patients with coronary artery disease | Q28182323 | ||
| Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases | Q28182631 | ||
| Low-dose aspirin for the prevention of atherothrombosis | Q28193680 | ||
| Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials | Q28194551 | ||
| Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus | Q28194890 | ||
| A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease | Q28195458 | ||
| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events | Q28195656 | ||
| Sex differences in platelet reactivity and response to low-dose aspirin therapy | Q28195867 | ||
| Aspirin and coronary artery disease | Q28211255 | ||
| Gender differences in the effect of aspirin on retinal ischemia, prostanoid synthesis and nitric oxide production in experimental type 1-like diabetes | Q28217377 | ||
| A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women | Q28218670 | ||
| Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
| Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data | Q30587054 | ||
| Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis. | Q33529765 | ||
| Gender dependence for a subset of the low-abundance signaling proteome in human platelets | Q34219541 | ||
| Representation of elderly persons and women in published randomized trials of acute coronary syndromes | Q34331421 | ||
| Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid | Q34447873 | ||
| Effect of gender difference on platelet reactivity | Q35473568 | ||
| Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study | Q36255692 | ||
| Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons | Q36536790 | ||
| Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause | Q36758718 | ||
| Ageing, oestrogen, platelets and thrombotic risk | Q36864696 | ||
| Estrogen, inflammation, and platelet phenotype | Q37131848 | ||
| Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score | Q37156100 | ||
| The hemostatic system through aging and menopause. | Q37610388 | ||
| Women with atrial fibrillation: Greater risk, less attention | Q37619865 | ||
| The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis | Q37631913 | ||
| Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis. | Q37693951 | ||
| Gender and the renin-angiotensin-aldosterone system | Q37770594 | ||
| Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease | Q37989677 | ||
| Metabolic correlates of menopause: an update | Q38058692 | ||
| Antiplatelets in acute coronary syndrome: personal perspectives. | Q38068595 | ||
| High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. | Q38484239 | ||
| A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective | Q39508367 | ||
| Sex and age differences in human platelet aggregation | Q41788899 | ||
| Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement | Q43190644 | ||
| Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry | Q43209366 | ||
| Gender and responses to aspirin and clopidogrel: insights using short thrombelastography | Q43244933 | ||
| Gender differences in the cardiovascular effect of sex hormones | Q43672165 | ||
| Vascular reactivity in men and women of reproductive age. | Q43694665 | ||
| Sex differences in the antithrombotic effects of aspirin | Q44208803 | ||
| Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel | Q44305048 | ||
| Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study | Q44307928 | ||
| Platelet reactivity and thrombogenicity in postmenopausal women | Q44774652 | ||
| Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. | Q45336086 | ||
| Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele | Q46119763 | ||
| Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up | Q46178120 | ||
| Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting | Q46322166 | ||
| Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk | Q46329223 | ||
| Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q46522937 | ||
| Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients | Q50112664 | ||
| Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. | Q50351428 | ||
| Gender differences in platelet GPIIb-IIIa activation. | Q50957931 | ||
| Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. | Q51110383 | ||
| Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy. | Q51297895 | ||
| Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). | Q53123407 | ||
| Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials | Q56944618 | ||
| Impact of race and gender on antithrombotic therapy | Q57764560 | ||
| Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors | Q59356191 | ||
| High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers | Q60678731 | ||
| Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients | Q60678799 | ||
| RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 | Q69755626 | ||
| A prospective study of aspirin use and primary prevention of cardiovascular disease in women | Q70215146 | ||
| Sex difference in the effect of aspirin on intracellular Ca2+ mobilization and thromboxane A2 production in rat platelets | Q70290269 | ||
| Sex differences in the anticoagulant effects of warfarin | Q72576827 | ||
| The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects | Q72783482 | ||
| The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group | Q73396117 | ||
| CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group | Q73422585 | ||
| Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment | Q73824699 | ||
| Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) | Q79839663 | ||
| Platelet counts differ by sex, ethnicity, and age in the United States | Q81397187 | ||
| Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis | Q85575497 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 72-81 | |
| P577 | publication date | 2014-01-28 | |
| P1433 | published in | Journal of Cardiovascular Translational Research | Q6294906 |
| P1476 | title | Gender and anti-thrombotic therapy: from biology to clinical implications | |
| P478 | volume | 7 |
| Q48689443 | Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy |
| Q90440684 | Impact of gender on immature platelet count and its relationship with coronary artery disease |
| Q30278548 | Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine. |
Search more.